The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
124465862 12446586 2 F 20150911 20160623 20160608 20160701 EXP JP-ASTRAZENECA-2016SE59420 ASTRAZENECA 25775.00 DY F Y 60.00000 KG 20160701 MD JP JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
124465862 12446586 1 PS IRESSA GEFITINIB 1 Oral 206995 250 MG TABLET QD
124465862 12446586 2 SS IRESSA GEFITINIB 1 Oral 206995 250 MG TABLET QOD
124465862 12446586 3 SS IRESSA GEFITINIB 1 Oral 206995 250 MG TABLET QD
124465862 12446586 4 C CRESTOR ROSUVASTATIN CALCIUM 1 Oral 0 2.5 MG TABLET QD
124465862 12446586 5 C BLOPRESS CANDESARTAN CILEXETIL 1 0 4 MG QD
124465862 12446586 6 C AZILVA AZILSARTAN KAMEDOXOMIL 1 0 10 MG QD
124465862 12446586 7 C OXATOMIDE OXATOMIDE 1 0 2 DF QD
124465862 12446586 8 C SILECE FLUNITRAZEPAM 1 0 1 MG QD
124465862 12446586 9 C SILECE FLUNITRAZEPAM 1 0 1 MG QD
124465862 12446586 10 C ALLELOCK OLOPATADINE HYDROCHLORIDE 1 0 5 MG BID
124465862 12446586 11 C VITANEURIN 2 0 25 MG CAPSULE TID
124465862 12446586 12 C MINOCYCLINE HYDROCHLORIDE. MINOCYCLINE HYDROCHLORIDE 1 0 50 MG BID
124465862 12446586 13 C CRAVIT LEVOFLOXACIN 1 0
124465862 12446586 14 C THIATON TIQUIZIUM BROMIDE 1 0 10 MG QD
124465862 12446586 15 C BIOFERMIN BACILLUS SUBTILISLACTOBACILLUS ACIDOPHILUSSTREPTOCOCCUS FAECAIS 1 1 GRAM, DAILY 0
124465862 12446586 16 C BIOFERMIN BACILLUS SUBTILISLACTOBACILLUS ACIDOPHILUSSTREPTOCOCCUS FAECAIS 1 3 GRAM DAILY 0
124465862 12446586 17 C CERCINE DIAZEPAM 1 0 5 MG QD
124465862 12446586 18 C TRIMEBUTINE MALEATE TRIMEBUTINE MALEATE 1 0 3 DF QD
124465862 12446586 19 C BIOFERMIN BACILLUS SUBTILISLACTOBACILLUS ACIDOPHILUSSTREPTOCOCCUS FAECAIS 1 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
124465862 12446586 1 Lung neoplasm malignant
124465862 12446586 2 Lung neoplasm malignant
124465862 12446586 3 Lung neoplasm malignant
124465862 12446586 4 Hyperlipidaemia
124465862 12446586 5 Hypertension
124465862 12446586 6 Hypertension

Outcome of event

Event ID CASEID OUTC COD
124465862 12446586 DS
124465862 12446586 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
124465862 12446586 Alopecia
124465862 12446586 Rash pruritic

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
124465862 12446586 1 20150630 20160211 0
124465862 12446586 2 20160212 20160616 0
124465862 12446586 3 20160617 0
124465862 12446586 4 20150821 0
124465862 12446586 5 20150821 20160218 0
124465862 12446586 6 20160219 0
124465862 12446586 7 20150911 0
124465862 12446586 8 20151030 0
124465862 12446586 9 201510 0
124465862 12446586 10 20160205 0
124465862 12446586 11 20160413 0
124465862 12446586 12 20160530 0
124465862 12446586 13 201507 201507 0
124465862 12446586 14 201508 201508 0
124465862 12446586 15 201508 201508 0
124465862 12446586 16 201603 201603 0
124465862 12446586 17 201510 201510 0
124465862 12446586 18 201603 201603 0